Correlation Between US Lithium and Regencell Bioscience

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both US Lithium and Regencell Bioscience at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining US Lithium and Regencell Bioscience into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between US Lithium Corp and Regencell Bioscience Holdings, you can compare the effects of market volatilities on US Lithium and Regencell Bioscience and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in US Lithium with a short position of Regencell Bioscience. Check out your portfolio center. Please also check ongoing floating volatility patterns of US Lithium and Regencell Bioscience.

Diversification Opportunities for US Lithium and Regencell Bioscience

0.7
  Correlation Coefficient

Poor diversification

The 3 months correlation between LITH and Regencell is 0.7. Overlapping area represents the amount of risk that can be diversified away by holding US Lithium Corp and Regencell Bioscience Holdings in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Regencell Bioscience and US Lithium is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on US Lithium Corp are associated (or correlated) with Regencell Bioscience. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Regencell Bioscience has no effect on the direction of US Lithium i.e., US Lithium and Regencell Bioscience go up and down completely randomly.

Pair Corralation between US Lithium and Regencell Bioscience

Given the investment horizon of 90 days US Lithium Corp is expected to under-perform the Regencell Bioscience. But the stock apears to be less risky and, when comparing its historical volatility, US Lithium Corp is 3.74 times less risky than Regencell Bioscience. The stock trades about -0.01 of its potential returns per unit of risk. The Regencell Bioscience Holdings is currently generating about 0.02 of returns per unit of risk over similar time horizon. If you would invest  2,800  in Regencell Bioscience Holdings on November 5, 2024 and sell it today you would lose (2,420) from holding Regencell Bioscience Holdings or give up 86.43% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthSignificant
Accuracy94.96%
ValuesDaily Returns

US Lithium Corp  vs.  Regencell Bioscience Holdings

 Performance 
       Timeline  
US Lithium Corp 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days US Lithium Corp has generated negative risk-adjusted returns adding no value to investors with long positions. Despite weak performance in the last few months, the Stock's basic indicators remain fairly strong which may send shares a bit higher in March 2025. The recent confusion may also be a sign of long-lasting up-swing for the firm traders.
Regencell Bioscience 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Regencell Bioscience Holdings has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of fragile performance in the last few months, the Stock's technical and fundamental indicators remain rather sound which may send shares a bit higher in March 2025. The latest tumult may also be a sign of longer-term up-swing for the firm shareholders.

US Lithium and Regencell Bioscience Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with US Lithium and Regencell Bioscience

The main advantage of trading using opposite US Lithium and Regencell Bioscience positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if US Lithium position performs unexpectedly, Regencell Bioscience can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Regencell Bioscience will offset losses from the drop in Regencell Bioscience's long position.
The idea behind US Lithium Corp and Regencell Bioscience Holdings pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Top Crypto Exchanges module to search and analyze digital assets across top global cryptocurrency exchanges.

Other Complementary Tools

Portfolio Analyzer
Portfolio analysis module that provides access to portfolio diagnostics and optimization engine
Portfolio Diagnostics
Use generated alerts and portfolio events aggregator to diagnose current holdings
Portfolio Anywhere
Track or share privately all of your investments from the convenience of any device
Equity Forecasting
Use basic forecasting models to generate price predictions and determine price momentum
Stocks Directory
Find actively traded stocks across global markets